• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECKMAN COULTER ACCESS HYBRITECH PSA REAGENT; PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECKMAN COULTER ACCESS HYBRITECH PSA REAGENT; PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS Back to Search Results
Catalog Number 37200
Device Problem High Test Results (2457)
Patient Problem No Code Available (3191)
Event Date 09/11/2017
Event Type  Injury  
Manufacturer Narrative
Patient demographics such as age, date of birth, weight, race and ethnicity were not supplied.A beckman coulter (bec) field service engineer (fse) was not dispatched to the customer's laboratory to assess instrument performance as the customer was not questioning the performance in conjunction with this event.All of the system parameters, including quality controls (qc), calibrations and system checks were performing with instrument specifications at the time of the event.The access hybritech psa reagent was not returned to bec for further investigation.No further information is available regarding the performance of the reagent.There were no reports of error messages, system flags or issues with other patients/assays in conjunction with this event.The customer sent the patient's sample to the bec complaint handling unit (chu) in (b)(4) for further investigative testing.The bec chu performed initial neat sample testing and obtained a significantly lower result than the customer.The customer's event could not be confirmed.Further evaluation of the patient's sample was not warranted.In conclusion, the cause of this incident is unknown and unknowable with the information supplied.
 
Event Description
The customer reported obtaining a higher than expected prostate-specific antigen (access hybritech psa) result for one (1) patient on the laboratory's unicel dxi 800 access immunoassay system (serial (b)(4)).The physician questioned the result as the patient had previously undergone a radical prostatectomy (date of procedure is unknown).On (b)(6) 2017, the patient's prostate-specific antigen (psa) was tested at a reference laboratory ((b)(6)) on an alternate methodology (roche) and a significantly lower result was obtained.Another sample from this patient was also tested at a second reference laboratory (quest), on (b)(6) 2017, on a unicel dxi 800 access immunoassay system (serial number unknown) and a second higher than expected result was obtained.On (b)(6) 2017 another sample from the patient's was collected and sent to the beckman coulter (bec) complaint handling unit (chu) for testing.The customer stated the initial access hybritech psa result was reported outside the laboratory.The patient underwent an unknown hormone therapy as a result of the higher than expected access hybritech psa result obtained.The hormone therapy was discontinued once it was determined that the patient's psa results did not significantly change.The customer noted that the access hybritech psa quality controls (qc), assay calibration, and system check were performing within specifications at the time of the event.There were no error messages, hardware issues or other assay problems reported in conjunction with this event.The patient's sample was collected in a plastic serum tube with a gel separator and analyzed from the primary tube.Specific sample information was not supplied such as centrifugation time and speed.The customer did not report any issues with sample integrity.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACCESS HYBRITECH PSA REAGENT
Type of Device
PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS
Manufacturer (Section D)
BECKMAN COULTER
1000 lake hazeltine drive
chaska MN 55318
Manufacturer (Section G)
BECKMAN COULTER
1000 lake hazeltine drive
chaska MN 55318
Manufacturer Contact
angela kilian
1000 lake hazeltine drive
chaska, MN 55318
MDR Report Key6968743
MDR Text Key89960000
Report Number2122870-2017-00052
Device Sequence Number1
Product Code LTJ
UDI-Device Identifier15099590224592
UDI-Public(01)15099590224592(17)180531(11)170603(10)723528
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K974816
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 09/26/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/23/2017
Is this an Adverse Event Report? Yes
Device Operator Health Professional
Device Expiration Date05/31/2018
Device Catalogue Number37200
Device Lot Number723528
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received09/26/2017
Was Device Evaluated by Manufacturer? No
Date Device Manufactured06/03/2017
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Other;
-
-